Circulating oncometabolite 2-hydroxyglutarate (2HG) as a potential surrogate biomarker in patients with isocitrate dehydrogenase mutant (IDHm) intrahepatic cholangiocarcinoma (ICC).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lipika Goyal, Darrell R. Borger, Thomas Yau, Ronnie Tung Ping Poon, Marek Ancukiewicz, David C. Christiani, Hannah M. Liebman, Katharine Yen, Kimberly Straley, Samuel V. Agresta, Jason Edward Faris, Eunice Lee Kwak, Jeffrey W. Clark, David P. Ryan, Kenneth Tanabe, Vikram Deshpande, Rakesh K. Jain, Anthony John Iafrate, Dan G. Duda, Andrew X. Zhu
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2214962437